Literature DB >> 33871751

Acute severe ulcerative colitis: management advice for internal medicine and emergency physicians-comment.

Jayendra Shukla1, Anuraag Jena1, Vishal Sharma2.   

Abstract

Entities:  

Keywords:  Acute severe colitis; Colectomy; Cyclosporine; Inflammatory bowel disease; Ulcerative colitis

Mesh：

Substances：

Year:  2021        PMID： 33871751     DOI： 10.1007/s11739-021-02739-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

1.  Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis.

Authors:  Jacob E Ollech; Sujaata Dwadasi; Victoria Rai; Noam Peleg; Inessa Normatov; Amanda Israel; Philip H Sossenheimer; Britt Christensen; Joel Pekow; Sushila R Dalal; Atsushi Sakuraba; Russell D Cohen; David T Rubin
Journal:  Aliment Pharmacol Ther       Date:  2019-12-25       Impact factor: 8.171

2.  Cyclosporine-associated neurotoxicity. The need for a better guide for immunosuppressive therapy.

Authors:  L W Miller
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

3.  Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease.

Authors:  Michael B Sternthal; Seamus J Murphy; James George; Asher Kornbluth; Simon Lichtiger; Daniel H Present
Journal:  Am J Gastroenterol       Date:  2008-01-02       Impact factor: 10.864

4.  Adjuvant use of combination of antibiotics in acute severe ulcerative colitis: A placebo controlled randomized trial.

Authors:  Shubhra Mishra; Harshal S Mandavdhare; Harjeet Singh; Arup Choudhury; Jimil Shah; Sant Ram; Dimple Kalsi; Jayanta Samanta; Kaushal K Prasad; Arun K Sharma; Usha Dutta; Vishal Sharma
Journal:  Expert Rev Anti Infect Ther       Date:  2020-12-14       Impact factor: 5.091

Review 5.  Acute severe ulcerative colitis: management advice for internal medicine and emergency physicians.

Authors:  Konstantina Rosiou; Christian Philipp Selinger
Journal:  Intern Emerg Med       Date:  2021-03-22       Impact factor: 3.397
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.